Rigel Pharmaceuticals, Inc. Common Stock

RIGL US7665596034

💰
Capitalization
Small-cap

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

🔗
Website
https://www.rigel.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
14
🙍
Insiders
4
Person Price Shares Total Published Completed
Schorno Dean L
EX VP 		21.93
USD 		1,734
Sold 		38,020
USD 		04/02/2025 05/02/2025
Santos David A
EX VP 		21.93
USD 		1,796
Sold 		39,379
USD 		04/02/2025 05/02/2025
Rodriguez Raul R
CEO 		21.93
USD 		4,400
Sold 		96,474
USD 		04/02/2025 05/02/2025
Furey Raymond J.
CCO 		21.93
USD 		1,339
Sold 		29,359
USD 		04/02/2025 05/02/2025
Schorno Dean L
EX VP 		20.92
USD 		2,036
Sold 		42,595
USD 		04/02/2025 04/02/2025
Rodriguez Raul R
CEO 		20.92
USD 		4,952
Sold 		103,601
USD 		04/02/2025 04/02/2025
Santos David A
EX VP 		20.92
USD 		2,125
Sold 		44,457
USD 		04/02/2025 04/02/2025
Furey Raymond J.
CCO 		20.92
USD 		1,448
Sold 		30,294
USD 		04/02/2025 04/02/2025
Schorno Dean L
EX VP 		1.14
USD 		7,027
Sold 		8,011
USD 		02/02/2024 05/02/2024
Rodriguez Raul R
CEO 		1.14
USD 		30,545
Sold 		34,821
USD 		02/02/2024 05/02/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Rigel Pharmaceuticals, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Rodriguez Raul R 4 260,157.56 65,039.39 02/02/2024 05/02/2025
Santos David A 4 100,331.88 25,082.97 02/02/2024 05/02/2025
Schorno Dean L 4 94,952.51 23,738.13 02/02/2024 05/02/2025
Furey Raymond J. 2 59,652.52 29,826.26 04/02/2025 05/02/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.